Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.94 USD | -0.73% | +5.37% | -12.75% |
05-07 | Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
05-07 | Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.75% | 1.9B | |
+33.50% | 49.46B | |
+1.78% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.58% | 26.61B | |
-21.64% | 18.64B | |
+7.88% | 13.16B | |
+29.66% | 12.55B | |
+23.43% | 12.1B |
- Stock Market
- Equities
- BEAM Stock
- News Beam Therapeutics Inc.
- Citigroup Adjusts Beam Therapeutics Price Target to $56 From $60, Maintains Buy Rating